A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients

Early imaging or blood biomarkers of tumor response are desperately needed to customize antiangiogenic therapy for cancer patients. Anti–vascular endothelial growth factor (VEGF) therapy can “normalize” brain tumor vasculature by decreasing vessel diameter and permeability, and thinning the abnormal...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sorensen, A. Gregory, Batchelor, Tracy T., Zhang, Wei-Ting, Chen, Poe-Jou, Yeo, Priscilla, Wang, Meiyun, Jennings, Dominique, Wen, Patrick Y., Lahdenranta, Johanna, Ancukiewicz, Marek, di Tomaso, Emmanuelle, Duda, Dan G., Jain, Rakesh K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2824172/
https://ncbi.nlm.nih.gov/pubmed/19549889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-09-0814
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados